Cover Image
Market Research Report

Central Nervous System Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

Published by The Business Research Company Product code 531325
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Central Nervous System Drugs Global Market Report 2020-30: Covid 19 Implications and Growth
Published: May 19, 2020 Content info:
Description

‘Central Nervous System Drugs Global Market Report 2020-30: Covid 19 Implications and Growth ’ from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for central nervous system drugs which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the central nervous system drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Central Nervous System Drugs Market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider central nervous system drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the central nervous system drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, central nervous system drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Other CNS drugs

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Biogen Inc; F. Hoffmann-La Roche Ltd; Johnson & Johnson; Pfizer Inc; Novartis AG

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, central nervous system drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Table of Contents

1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Central Nervous System Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis

  • 9.1. Global Central Nervous System Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation

  • 10.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Analgesics

Anti-Parkinson drugs

Anesthetics

Anti-Epileptics

Other CNS drugs

  • 10.2. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Central Nervous System Drugs Market Metrics

  • 11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Central Nervous System Drugs Market

  • 12.1. Asia-Pacific Central Nervous System Drugs Market Overview
  • 12.2. Asia-Pacific, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics
    • 12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Asia-Pacific Countries
    • 12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Asia-Pacific Countries
  • 12.6. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis
    • 12.7.1. China Central Nervous System Drugs Market
      • 12.7.1.1. China Central Nervous System Drugs Market Overview
      • 12.7.1.2. China Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Central Nervous System Drugs Market
      • 12.7.2.1. Australia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Central Nervous System Drugs Market
      • 12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Central Nervous System Drugs Market
      • 12.7.4.1. India Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Central Nervous System Drugs Market
      • 12.7.5.1. Indonesia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Central Nervous System Drugs Market
      • 12.7.6.1. Japan Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Central Nervous System Drugs Market
      • 12.7.7.1. Malaysia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Central Nervous System Drugs Market
      • 12.7.8.1. New Zealand Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Central Nervous System Drugs Market
      • 12.7.9.1. Philippines Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Central Nervous System Drugs Market
      • 12.7.10.1. Singapore Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Central Nervous System Drugs Market
      • 12.7.11.1. South Korea Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Central Nervous System Drugs Market
      • 12.7.12.1. Thailand Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Central Nervous System Drugs Market
      • 12.7.13.1. Vietnam Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Central Nervous System Drugs Market

  • 13.1. Western Europe Central Nervous System Drugs Market Overview
  • 13.2. Western Europe, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Central Nervous System Drugs Market Metrics
    • 13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Western Europe Countries
    • 13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Western Europe Countries
  • 13.6. Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Central Nervous System Drugs Market: Country Analysis
    • 13.7.1. Austria Central Nervous System Drugs Market
      • 13.7.1.1. Austria Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Central Nervous System Drugs Market
      • 13.7.2.1. Belgium Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Central Nervous System Drugs Market
      • 13.7.3.1. Denmark Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Central Nervous System Drugs Market
      • 13.7.4.1. Finland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Central Nervous System Drugs Market
      • 13.7.5.1. France Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Central Nervous System Drugs Market
      • 13.7.6.1. Germany Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Central Nervous System Drugs Market
      • 13.7.7.1. Ireland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Central Nervous System Drugs Market
      • 13.7.8.1. Italy Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Central Nervous System Drugs Market
      • 13.7.9.1. Netherlands Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Central Nervous System Drugs Market
      • 13.7.10.1. Norway Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Central Nervous System Drugs Market
      • 13.7.11.1. Portugal Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Central Nervous System Drugs Market
      • 13.7.12.1. Spain Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Central Nervous System Drugs Market
      • 13.7.13.1. Sweden Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Central Nervous System Drugs Market
      • 13.7.14.1. Switzerland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Central Nervous System Drugs Market
      • 13.7.15.1. UK Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Central Nervous System Drugs Market

  • 14.1. Eastern Europe Central Nervous System Drugs Market Overview
  • 14.2. Eastern Europe, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Central Nervous System Drugs Market Metrics
    • 14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Eastern Europe Countries
    • 14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Eastern Europe Countries
  • 14.6. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Central Nervous System Drugs Market,
      • 14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Central Nervous System Drugs Market
      • 14.7.2.1. Poland Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Central Nervous System Drugs Market
      • 14.7.3.1. Romania Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Central Nervous System Drugs Market
      • 14.7.4.1. Russia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Central Nervous System Drugs Market

  • 15.1. North America Central Nervous System Drugs Market Overview
  • 15.2. North America, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Central Nervous System Drugs Market Metrics
    • 15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, North America Countries
    • 15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, North America Countries
  • 15.6. North America Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Central Nervous System Drugs Market: Country Analysis
    • 15.7.1. Canada Central Nervous System Drugs Market
      • 15.7.1.1. Canada Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Central Nervous System Drugs Market
      • 15.7.2.1. Mexico Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Central Nervous System Drugs Market
      • 15.7.3.1. USA Central Nervous System Drugs Market Overview
      • 15.7.3.2. USA Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Central Nervous System Drugs Market

  • 16.1. South America Central Nervous System Drugs Market Overview
  • 16.2. South America, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Central Nervous System Drugs Market Metrics
    • 16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, South America Countries
    • 16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, South America Countries
  • 16.6. South America Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Central Nervous System Drugs Market: Country Analysis
    • 16.7.1. Argentina Central Nervous System Drugs Market
      • 16.7.1.1. Argentina Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Central Nervous System Drugs Market
      • 16.7.1.1. Brazil Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Central Nervous System Drugs Market
      • 16.7.3.1. Chile Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Central Nervous System Drugs Market
      • 16.7.4.1. Colombia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Central Nervous System Drugs Market
      • 16.7.5.1. Peru Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Central Nervous System Drugs Market
      • 16.7.6.1. Venezuela Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Central Nervous System Drugs Market

  • 17.1. Middle East Central Nervous System Drugs Market Overview
  • 17.2. Middle East, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Central Nervous System Drugs Market Metrics
    • 17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Middle East Countries
    • 17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Middle East Countries
  • 17.6. Middle East Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Central Nervous System Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Central Nervous System Drugs Market
      • 17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Central Nervous System Drugs Market
      • 17.7.2.1. Israel Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Central Nervous System Drugs Market
      • 17.7.3.1. Turkey Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Central Nervous System Drugs Market
      • 17.7.4.1. UAE Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Central Nervous System Drugs Market

  • 18.1. Africa Central Nervous System Drugs Market Overview
  • 18.2. Africa, Central Nervous System Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Central Nervous System Drugs Market Metrics
    • 18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2015-2023, Africa Countries
    • 18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2019, Africa Countries
  • 18.6. Africa Central Nervous System Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Central Nervous System Drugs Market: Country Analysis
    • 18.7.1. Egypt Central Nervous System Drugs Market
      • 18.7.1.1. Egypt Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Central Nervous System Drugs Market
      • 18.7.2.1. Nigeria Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Central Nervous System Drugs Market
      • 18.7.3.1. South Africa Central Nervous System Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Central Nervous System Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Biogen Inc
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. F. Hoffmann-La Roche Ltd
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Johnson & Johnson
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Pfizer Inc
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Central Nervous System Drugs Market In 2023- Growth Countries
  • 22.2. Global Central Nervous System Drugs Market In 2023- Growth Segments
  • 22.3. Global Central Nervous System Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top